Antioxidants and mucosa protectives: Realistic therapeutic options in inflammatory bowel disease?

Mediators of Inflammation

Volumn 7, Issue 3, 1998, Pages 157-162

  Kruidenier, L ^a   Verspaget, H W ^a  

^a LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

Antioxidants; Butyrate; Crohn's disease; Fatty acids; Fish oil; Inflammatory bowel disease; Reactive oxygen metabolites; Superoxide dismutase; Ulcerative colitis

Indexed keywords

ANTIOXIDANT; FATTY ACID; FISH OIL; LONG CHAIN FATTY ACID; REACTIVE OXYGEN METABOLITE; SHORT CHAIN FATTY ACID; SUCRALFATE;

AUTOOXIDATION; CONFERENCE PAPER; CROHN DISEASE; DIET THERAPY; DRUG EFFICACY; ENTERITIS; HUMAN; INTESTINE MUCOSA; MALNUTRITION; MEDIATOR RELEASE; NONHUMAN; OXIDATIVE STRESS; PRIORITY JOURNAL; TISSUE INJURY; ULCERATIVE COLITIS;

ANTIOXIDANTS; FATTY ACIDS; HUMANS; INFLAMMATORY BOWEL DISEASES; INTESTINAL MUCOSA; REACTIVE OXYGEN SPECIES; SUCROSE;

ANIMALIA;

EID: 0031873448     PISSN: 09629351     EISSN: None     Source Type: Journal    
DOI: 10.1080/09629359891081     Document Type: Conference Paper

References (23)

1. Yamada T, Grisham MB. Pathogenesis of tissue injury: role of reactive metabolites of oxygen and nitrogen. In: Targan SR, Shanahan F, eds. Inflammatory Bowel Disease: From Bench to Bedside. Baltimore: Williams & Wilkins, 1994; 133-150.
2. Salim AS. Role of oxygen-derived free radical scavengers in the management of recurrent attacks of ulcerative colitis: a new approach. J Lab Clin Med 1992; 119: 710-717.
3. Levin KE, Pemberton JH, Phillips SF, Zinsmeister AR, Pezim ME. Role of oxygen free radicals in the etiology of pouchitis. Dis Colon Rectum 1992; 35: 452-486.
4. Keshavarzian A, Morgan G, Sedghi S, Gordon JH, Doria M. Role of reactive oxygen metabolites in experimental colitis Gut 1990; 31: 786-790.
5. Keshavarzian A, Doria MI, Sedghi S, et al. Mitomycin C-induced colitis in rats: a new animal model of acute colonic inflammation implicating reactive oxygen species. J Lab Clin Med 1992; 120: 778-791.
6. Fretland DJ, Widomski DL, Anglin CP. et al. Superoxide dismutase (SOD) modulates acetic acid-induced colitis in rodents. Gastroenterology 1991; 100: A581.
7. Burakoff R, Zhao L, Joseph I, Koo H. Rosenfeld W. SOD prevents colitis and attenuates eicosanoid release and motility changes in a trini-trobenzensulfonic acid rabbit colitis model. Gastroenterology 1991; 100: A565.
8. Emerit J, Pelletier S, Tosoni-Verlignue D, Mollet M. Phase II trial of copper zine superoxide dismutase (CuZnSOD) in treatment of Crohn's disease. Free Radical Biol Med 1989; 7: 145-149.
9. Niwa Y, Somiya K, Michelson AM, Puget K. Effect of liposomal-encapsulated superoxide dismutase on active oxygen-related human disorders. A preliminary study. Free Radical Res Comm 1985; 1: 137-153.
10. Hori Y, Hoshino J, Yamazaki C, et al. Effect of lecithinized-superoxide dismutase on the rat colitis model induced by dextran sodium sulphate. Jpn J Pharmacol 1997; 74: 99-103.
11. 1 decrease experimental colitis. Dig Dis Sci 1992; 37: 1866-1873.
12. Karmeli F, Eliakim R, Okon E, Samuni A, Rachmilewitz D. A stable nitroxide radical effectively decreases mucosal damage in experimental colitis. Gut 1995; 37: 386-393.
13. Yue G, Sun FF, Dunn C, Yin K, Wong PY-K. The 21-aminosteroid tirilazad mesylate can ameliorate inflammatory bowel disease in rats. J Pharmacol Exp Ther 1996; 276: 265-270.
14. Zea-Iriarte W-L, Makiyama K, Goto S, et al. Impairment of antioxidants in colonic epithelial cells isolated from trinitrobenzene sulphonic acidinduced colitis rats. Scand J Gastroenterol 1996; 31: 985-992.
15. Burke A, Lichtenstein GR, Rombeau JL. Nutrition and ulcerative colitis. Baillière Clin Gastroenterol 1997; 11: 153-174.
16. Yoshikawa T, Yamaguchi T, Yoshida N, et al. Effect of Z-103 on TNB-induced colitis in rats. Digestion 1997; 58: 464-468.
17. Mulder TPJ, Van der Sluys Veer A, Verspaget HW, et al. Effect of oral zinc supplementation on metallothionein and superoxide dismutase concentrations in patients with inflammatory bowel disease. J Gastroenterol Hepatol 1994; 9: 472-477.
18. Polson RJ, Misiewicz JJ. Medical management of severe inflammatory disease of the rectum and distal colon: non-nutritional aspects. Baillière Clin Gastroenterol 1992; 6: 1-26.
19. Kim YI. Short-chain fatty acids in ulcerative colitis. Nutr Rev 1998; 56: 17-24.
20. Beluzzi A, Brignola C, Campieri M, Pera A, Boschi S, Miglioli M. Effect of an enteric-coated fish-oil preparation on relapses in Crohn's disease. N Engl J Med 1996; 334: 1557-1560.
21. Blok WL, Katan MB, Van der Meer JWM. Modulation of inflammation and cytokine production by dietary (n-3) fatty acids. J Nutr 1996; 126: 1515-1533.
22. Venkatraman JT, Pinnavaia L. Effects of saturated, omega-6 and omega-3 lipids on activities of enzymes involved in antioxidant defense in normal rats. Nutr Res 1998; 18: 341-350.
23. Grisham MB, DeMichele SJ, Garleb KA, Specian RD. Sulfasalazine or enteral diets containing fish oil or oligosaccharides attenuate chronic colitis in rats. Inflamm Bowel Dis 1996; 2: 178-188.